Stocks · Health care · Pharmaceutical Preparations

PUMA BIOTECHNOLOGY, INC.

PBYI Clue Score62
United States Fiscal year ends December CIK 0001401667 Results filed 5 Nov 2026

What the insiders did No buying or selling

By person

11 insiders · 0 transactions
71.1×

Alan H. Auerbach holds 71.1 times base salary in stock. $66.25M of shares against $931.33K in salary for 2025.

Salary from the company's own proxy. The shares are what Alan H. Auerbach last reported holding, valued at $9.12, the price Common Stock was last bought or sold at on the open market here, on 14 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Alan H Auerbach
President and CEO
—
—
—
7,261,671
$66.25M
+2.8%
Maximo F Nougues
Chief Financial Officer
—
—
—
230,637
$2.10M
+41.9%
Douglas M Hunt
See Remarks
—
—
—
196,841
$1.80M
+47.7%
Jeffrey Jerome Ludwig
Chief Commercial Officer
—
—
—
156,792
$1.43M
+32.4%
Brian M Stuglik
Director
—
—
—
113,858
$1.04M
+49.7%
Allison Dorval
Director
—
—
—
90,780
$828.19K
+51.3%
Michael Patrick Miller
Director
—
—
—
81,000
$738.96K
+72.3%
Jay M Moyes
Director
—
—
—
58,322
$532.07K
+20.7%
Alessandra Cesano
Director
—
—
—
56,700
$517.27K
+5.0%
Troy Edward Wilson
Director
—
—
—
55,300
$504.50K
+98.2%
Adrian Senderowicz
Director
—
—
—
27,000
$246.32K
0.0%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.